“Sweet death”: Fructose as a metabolic toxin that targets the gut-liver axis
Year: 2021
Type: review
Source: Cell Metabolism
Authors: Mark A. Febbraio, Michael Karin
Institutions: Monash University, University of California San Diego
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors, Towards a better understanding of the health benefits of physical activity: designing exercise mimetic for the treatment of disease, NAFLD, NASH and Hepatocellular carcinoma: Mechanisms & Potential Treatments, G2582339796, G2695270899, A new treatment for type 2 diabetes, G2923567424, DETECTION AND MODELS OF TOXICANT EXPOSURE, A new anti-inflammatory treatment strategy to prevent metabolic diseases, The designer cytokine IC7: a novel therapy for the treatment of type 2 Diabetes, ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma, Development of novel therapies to treat obesity related metabolic diseases, G8630745202, Role of p62/SQSTM1 in obesity-induced liver cancer, Control of Lipogenesis and Hepatic Steatosis by Caspase-2, NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation
OpenAlex ID: W3202816718
